Pompano Beach, Florida, May 17, 2004 - PetMed Express, Inc. (NASDAQ: PETS) today announced results for the fiscal year ended March 31, 2004. Net income was $5.8 million, or $.30 per share, $.25 diluted per share, for fiscal 2004, compared to net income of $3.3 million or $.19 per share, $.16 diluted per share, for fiscal 2003, an increase of 79%. Net sales for the fiscal year ended March 31, 2004 were $94.0 million, compared to $55.0 million for the fiscal year ended March 31, 2003, an increase of 71%. PetMed Express also reported new customer growth of approximately 572,000 customers in fiscal 2004, compared with 414,000 in fiscal 2003.

For the quarter ended March 31, 2004, income before provision for income taxes was $2.2 million compared to $1.2 million for the quarter ended March 31, 2003, an increase of 83%. For the quarters ended March 31, 2004 and 2003, respectively, net income was $1.3 million and $1.7 million, the latter of which included a deferred tax asset eliminating the income tax provision and reflecting a tax benefit of $535,000. Net sales for the quarter ended March 31, 2004 were $21.5 million, compared to $14.9 million, an increase of 44%.

Mendo Akdag, CEO, commented: “We are very pleased with the sustained profitability and the incremental increase in sales over the past year. We are also proud to report that our reorder sales doubled from $25.8 million in fiscal 2003 to $51.4 million in fiscal 2004. Over the past three years our sales have grown from $10.0 million to $94.0 million, and the diluted earning per share has improved from $.28 loss per share to $.25 earnings per share, over the same period. We are excited about the future prospects for the company, and in anticipation of future growth we have completed the expansion to our warehouse/fulfillment operation. The expansion will increase our daily order capacity by approximately 40% as well as create additional warehouse space for inventory.”

Founded in 1996, PetMed Express is America’s largest pet pharmacy, delivering prescription and non-prescription pet medications, health and nutritional supplements at competitive prices through the PetMed Express catalog, customer service representatives, and on the Internet through its website at

This press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risk and uncertainties, including the Company’s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis or Plan of Operations in the PetMed Express Annual Report on Form 10-KSB for the year ended March 31, 2003 and the Quarterly Report on Form 10-Q for the quarter ended December 31, 2003.

For investment relations contact PetMed Express, Inc., Pompano Beach, Mendo Akdag, CEO, 954-979-5995.